First quarter of fiscal 2012 saw transformational change for Arrowhead
Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology and obesity, today announced financial results for its fiscal 2012 first quarter ended December 31, 2011. “The first quarter of fiscal...